CC

Casdin Capital Portfolio holdings

AUM $1.1B
1-Year Return 24.98%
This Quarter Return
-25.6%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$585M
AUM Growth
-$230M
Cap. Flow
-$14.9M
Cap. Flow %
-2.54%
Top 10 Hldgs %
58.39%
Holding
39
New
3
Increased
9
Reduced
8
Closed
6

Top Buys

1
SRPT icon
Sarepta Therapeutics
SRPT
+$12M
2
BLUE
bluebird bio
BLUE
+$7.14M
3
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$6.46M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$6.2M
5
IBB icon
iShares Biotechnology ETF
IBB
+$5.79M

Top Sells

1
SGMO icon
Sangamo Therapeutics
SGMO
+$10.6M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$9.76M
3
OSUR icon
OraSure Technologies
OSUR
+$8.11M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$6.9M
5
AGIO icon
Agios Pharmaceuticals
AGIO
+$6.21M

Sector Composition

1 Healthcare 85.67%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CNST
26
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$6.24M 1.07%
1,556,998
+242,255
+18% +$972K
IBB icon
27
iShares Biotechnology ETF
IBB
$5.67B
$5.79M 0.99%
+60,000
New +$5.79M
CDNA icon
28
CareDx
CDNA
$755M
$5.03M 0.86%
200,000
– –
DNLI icon
29
Denali Therapeutics
DNLI
$1.94B
$2.07M 0.35%
+100,000
New +$2.07M
QTNT
30
DELISTED
Quotient Limited Ordinary Shares
QTNT
$1.99M 0.34%
+8,125
New +$1.99M
NTGN
31
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$1.33M 0.23%
263,344
-75,001
-22% -$377K
CRSP icon
32
CRISPR Therapeutics
CRSP
$5.57B
– –
-220,000
Closed -$9.76M
CTMX icon
33
CytomX Therapeutics
CTMX
$323M
– –
-207,500
Closed -$3.84M
GILD icon
34
Gilead Sciences
GILD
$138B
– –
0
– –
NEOG icon
35
Neogen
NEOG
$1.15B
– –
-130,000
Closed -$4.65M
OSUR icon
36
OraSure Technologies
OSUR
$236M
– –
-525,000
Closed -$8.11M
JNCE
37
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-375,000
Closed -$2.44M
CLVS
38
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-235,000
Closed -$6.9M
CELG
39
DELISTED
Celgene Corp
CELG
– –
0
– –
1
2